TEICHA ALEXIS: Open Payments
NPI 1841958105 · BATON ROUGE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$812 in 36 payments from 16 companies in 2025. Trend: 2023 $701 · 2024 $1,062 · 2025 $812
Food & beverage: $812
| Company | Payments | Amount |
|---|---|---|
| Fresenius USA Marketing, Inc. | 5 | $112 |
| Otsuka America Pharmaceutical, Inc. | 5 | $104 |
| Novartis Pharmaceuticals Corporation | 3 | $81 |
| NxStage Medical, Inc. | 1 | $76 |
| Mallinckrodt Hospital Products Inc. | 4 | $73 |
| Calliditas Therapeutics US Inc. | 3 | $63 |
| Lilly USA, LLC | 3 | $56 |
| Novo Nordisk Inc | 3 | $54 |
| Alexion Pharmaceuticals, Inc. | 2 | $42 |
| AKEBIA THERAPEUTICS INC | 1 | $38 |
Products named: VELPHORO, JYNARQUE, NXSTAGE SYSTEM ONE, TARPEYO, ACTHAR, JARDIANCE, Fabhalta, ULTOMIRIS.
Industry payments across LA — which companies pay providers there.
